MedPath

Exercise Training on Brain Insulin Responsiveness

Not Applicable
Recruiting
Conditions
Insulin Resistance
Obesity
Interventions
Behavioral: waiting control
Behavioral: single bout of moderate intensity continuous training (MICT)
Behavioral: single bout of High Intensity Interval Training (HIIT)
Registration Number
NCT06039787
Lead Sponsor
University Hospital Tuebingen
Brief Summary

The overarching goal of the current study is to investigate the effect of one acute bout of exercise on the brain insulin responsiveness in a cross-over study design. To this end, investigators will compare the effect of two single endurance exercise sessions with different intensities, namely moderate intensity continuous training (MICT) and high-intensity-interval-training (HIIT), which will be performed in a randomized order. This will be compared to a waiting control condition.

Detailed Description

Investigate one acute bout of exercise on the brain insulin responsiveness using functional magnetic resonance imaging in combination with intranasal insulin in healthy participants of normal-weight and overweight/obesity. Two single endurance exercise sessions with different intensities will be evaluated, namely moderate intensity continuous training (MICT) and high-intensity interval training (HIIT). This will be compared to a waiting control condition. In a cross-over design, investigators will compare cerebral response from before to after intranasal insulin administration after a single bout of HIIT or MICT compared to a control condition without exercise. Cerebral response is defined as the cerebral blood flow and resting state functional connectivity in response to intranasal insulin. Secondary outcomes include changes in blood metabolites and proteins and changes in eating behavior.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • BMI between ≥ 19.5 to 39 kg/m2-
  • Less than 150 min/week for moderate-intensity physical activity
  • Less than 75 min/week for Vigorous- intensity exercise (WHO recommendations for regular physical activity of adults)
  • Written consent to participate in the study
  • Written consent to be informed about incidental findings

Exclusion Criteria

  • Type 2 diabetes, cardiovascular diseases such as chronic heart failure, myocardial infarction, status post stroke
  • Limitations to participate in ergometer-based exercise (balance and coordination disorders, orthopedic problems, ...)
  • Insufficient knowledge of the German language
  • Persons who cannot legally give consent
  • Pregnancy or lactation
  • History of severe mental or somatic disorders including neurological diseases (incl. epileptic seizures and migraines)
  • Taking psychotropic drugs
  • Taking medications that influence glucose metabolism
  • Regular use of analgesic drugs
  • Taking anticoagulant agents
  • Previous bariatric surgery
  • Acute infection within the last 4 weeks
  • Hemoglobin values less than 12g/dl for women, less than 14 g/dl for men
  • Other diseases that in the opinion of the investigator may jeopardize the success of the study or indicate a risk to the volunteer
  • Current participation in a lifestyle intervention study or a pharmaceutical study
  • Metal implants which cannot be removed as pacemakers, artificial heart valve, electrical devices as insulin pumps, large tattoos, retainer over more than 4 teeth, contraceptive coil, implanted magnetic metal parts as screws or plates after a surgery
  • Persons with claustrophobia
  • Temperature-sensitive person
  • Persons with tinnitus or increased sensitivity to loud sounds
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Waiting conditionwaiting control-
moderate intensity continuous trainingsingle bout of moderate intensity continuous training (MICT)-
High-intensity interval trainingsingle bout of High Intensity Interval Training (HIIT)-
Primary Outcome Measures
NameTimeMethod
Cerebral response after intranasal insulin administration1 hour after exercise or waiting control

The resting-state cerebral response from before to after intranasal insulin administration after a single bout of HIIT or MICT exercise compared to a control condition without exercise (i.e., waiting control)

Secondary Outcome Measures
NameTimeMethod
Task based brain activation after high-intensity-interval-training (HITT) or moderate intensity continuous training (MICT) compared to control condition1 hour after exercise or waiting control

Food cue reactivity after a single bout of HIIT or MICT exercise compared to a control condition without exercise (i.e., waiting control)

Subjective feeling of hunger and food cravingbaseline, 1 hour after breakfast, 1 hour, 2 hour, 3 hours after exercise or waiting control

Questionnaire assessment before and after exercise or waiting control.

Changes in Blood-brain barrier integrity1 hour after exercise or waiting control

Robust multiple echo-time arterial spin labelling based Blood Brain Barrier integrity measurements from before to after intranasal insulin administration after a single bout of HIIT or MICT exercise compared to a control condition without exercise (i.e., waiting control)

Performance during cognitive tasks1 hour after exercise or waiting control

Cambridge Cognition Tests Battery to assess memory and inhibitory control using the paired associates learning task, the pattern recognition memory task and the stop-signal reaction task.

Changes in exerkines from plasma samplesbaseline, 1 hour after breakfast, 1 hour, 2 hour, 3 hours after exercise or waiting control

Blood sampling at 5 time points before and after a single bout of HIIT or MICT exercise compared to a control condition without exercise (i.e., waiting control)

Change in incretins from plasma samplesbaseline, 1 hour after breakfast, 1 hour, 2 hour, 3 hours after exercise or waiting control

Blood sampling at 5 time points before and after a single bout of HIIT or MICT exercise compared to a control condition without exercise (i.e., waiting control)

Trial Locations

Locations (1)

University Clinic Tübingen, Department of Internal Medicine IV

🇩🇪

Tübingen, Germany

© Copyright 2025. All Rights Reserved by MedPath